Mar 11, 2021
But just how safe are COVID-19 vaccines, really? Dr.
Joel Gelfand offers us the answer, and it's a relief. Listen in for
practical tips for patients on biologics and with other existing
skin conditions. Each Thursday, join Dr. Raja and Dr. Hadar,
board-certified dermatologists, as they share the latest
evidence-based research in integrative dermatology. For access to
CE/CME courses, become a member at LearnSkin.com.
Dr. Joel M. Gelfand is Assistant Professor of Dermatology and
Epidemiology, Senior Scholar, Center for Clinical Epidemiology and
Biostatistics, Associate Fellow, Center for Public Health
Initiatives, Medical Director of the Clinical Studies Unit in the
Department of Dermatology, and a Member of the Cancer Center and
Institute for Translational Medicine and Therapeutics, all at the
University of Pennsylvania. Additionally, he is the principal
investigator for the Dermatology Clinical Effectiveness Research
Network (DCERN), a multi-center study evaluating the effectiveness
of treatments for moderate to severe psoriasis, founded by an RC1
grant from NIAMS. He is a board-certified dermatologist whose
clinical work focuses on general dermatology and psoriasis.